{
  "trial_id": "NCT03657797",
  "trial_group": "hypertension",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, race, baseline intraocular pressure (IOP), best-corrected visual acuity (BCVA), medical history, prior use of IOP-lowering medication, corneal thickness, presence of systemic diseases, history of ocular surgery or trauma.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Study Eye Baseline Mean Diurnal IOP (mmHg)",
          "baseline intraocular pressure (IOP)"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "best-corrected visual acuity (BCVA)",
        "medical history",
        "prior use of IOP-lowering medication",
        "corneal thickness",
        "presence of systemic diseases",
        "history of ocular surgery or trauma."
      ]
    },
    "processed-gen-response": "Age, gender, race, baseline intraocular pressure (IOP), best-corrected visual acuity (BCVA), medical history, prior use of IOP-lowering medication, corneal thickness, presence of systemic diseases, history of ocular surgery or trauma."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Baseline Intraocular Pressure (IOP), Best-Corrected Visual Acuity (BCVA), Duration of Glaucoma or Ocular Hypertension, Use of IOP-lowering medication,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Study Eye Baseline Mean Diurnal IOP (mmHg)",
          "Baseline Intraocular Pressure (IOP)"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Best-Corrected Visual Acuity (BCVA)",
        "Duration of Glaucoma or Ocular Hypertension",
        "Use of IOP-lowering medication"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Baseline Intraocular Pressure (IOP), Best-Corrected Visual Acuity (BCVA), Duration of Glaucoma or Ocular Hypertension, Use of IOP-lowering medication"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Diagnosis of open-angle glaucoma or ocular hypertension, Baseline IOP, Best-corrected visual acuity (BCVA), Corneal thickness, Anterior chamber angles, History of ocular surgery or trauma, Systemic disease status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Study Eye Baseline Mean Diurnal IOP (mmHg)",
          "Baseline IOP"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Diagnosis of open-angle glaucoma or ocular hypertension",
        "Best-corrected visual acuity (BCVA)",
        "Corneal thickness",
        "Anterior chamber angles",
        "History of ocular surgery or trauma",
        "Systemic disease status."
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Diagnosis of open-angle glaucoma or ocular hypertension, Baseline IOP, Best-corrected visual acuity (BCVA), Corneal thickness, Anterior chamber angles, History of ocular surgery or trauma, Systemic disease status."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, weight, height, body mass index (BMI), diagnosis (open-angle glaucoma or ocular hypertension), best-corrected visual acuity (BCVA), qualifying intraocular pressure (IOP) at baseline, number of previous glaucoma surgeries, presence of systemic diseases (e.g., diabetes, hypertension), use of IOP-lowering medications at baseline.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Study Eye Baseline Mean Diurnal IOP (mmHg)",
          "qualifying intraocular pressure (IOP) at baseline"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "weight",
        "height",
        "body mass index (BMI)",
        "diagnosis (open-angle glaucoma or ocular hypertension)",
        "best-corrected visual acuity (BCVA)",
        "number of previous glaucoma surgeries",
        "presence of systemic diseases (e.g., diabetes, hypertension)",
        "use of IOP-lowering medications at baseline."
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, weight, height, body mass index (BMI), diagnosis (open-angle glaucoma or ocular hypertension), best-corrected visual acuity (BCVA), qualifying intraocular pressure (IOP) at baseline, number of previous glaucoma surgeries, presence of systemic diseases (e.g., diabetes, hypertension), use of IOP-lowering medications at baseline."
  }
}